Kura Oncology KURA Insider Ownership

NASDAQ KURA

$9.88 -0.10 (-1.00%)

At close: Oct 21, 2026 · 4:00 PM EDT

Insider Holdings by Owner

1.53Mn Shares

Insider Ownership Statistics

as of 30 Sep, 2026

Insider Ownership

2.45%

▲+0.088% pp QoQ

Shares Held by Insiders

2.18Mn

filed for Sep 2026

▲+3.74% QoQ

Shares Outstanding

88.95Mn

88,954,000 shares

Direct Holdings

1.26Mn

Indirect: 918.75K

Net Shares Traded (QoQ)

+78.62K

net buying in Sep 2026

Insiders Holding Shares

with Form 4 holdings on file

Shares Owned by Insiders

Shares held % of outstanding

Latest —

Average ownership —

Peak ownership —

Shares Purchased/Sold by Insiders

Bought Sold

Latest quarter —

Net over range —

Buying quarters —

Insider Ownership Summary

Updated Oct 10, 2026

Over the trailing 12 months, KURA insiders bought $2.35 million worth of shares (200K shares) and sold $3.84 million worth (368.07K shares) in open-market trades.

Behind Kura Oncology's open-market trades in the past 12 months were one insider buying and 7 insiders selling.
Among KURA insiders, Troy Edward Wilson (President and CEO) bought the most stock on the open market in the past 12 months: $2.35 million (200K shares), most recently on August 24, 2026.
On the selling side, Mollie Leoni (Chief Medical Officer) was the top open-market seller of Kura Oncology over the past 12 months, with $1.52 million sold (149.84K shares) and the latest sale on September 29, 2026.
Beyond open-market trades, insiders at Kura Oncology received 410.12K shares in stock awards and acquired 91.1K shares through option exercises and conversions in the last 12 months.
Per Business Quant data, Kura Oncology insiders hold 2.18Mn shares in total based on their latest Form 4 filings, or 2.45% of the 88.95Mn shares outstanding; that total is up 3.74% from 2.1Mn shares at the end of Q2 2026.
Of the 2.18Mn shares held by Kura Oncology insiders, 1.26Mn shares (57.87%) are held directly and 918.75K shares (42.13%) indirectly, through trusts, partnerships, family members and other entities.
Holdings in Kura Oncology stock are reported by 9 insiders, the officers, directors and 10% owners who have filed a Form 4 in the past two years.
Kura Oncology's three biggest insider holders are Troy Edward Wilson (President and CEO, 1.21Mn shares), Teresa Brophy Bair (Chief Legal Officer, 187K shares) and Thomas Malley (Director, 149.56K shares), based on their latest Form 4 filings.
The largest insider, Troy Edward Wilson, holds 55.70% of KURA's insider total.
In the past year, 15 insiders of Kura Oncology submitted 46 Form 4 filings reporting trades, awards or other transactions.
The insider data for KURA reflects Form 4 filings through September 29, 2026.

Form 4 Holdings

Insiders Holding KURA

Insiders 12

Shares held 1.53Mn

Of outstanding 1.72%

#	Insider	Position	Direct	Indirect	Total	Share of Insiders	Last Filed
1	Troy Edward Wilson	President And Ceo	0	479,194	479,194	31.4%	24 Aug, 2026
2	Teresa Brophy Bair	Chief Legal Officer	187,002	0	187,002	12.2%	29 Sep, 2026
3	Thomas Malley	Director	10,000	139,557	149,557	9.8%	19 Mar, 2026
4	Kathleen Ford	Chief Operating Officer	142,986	0	142,986	9.4%	29 Sep, 2026
5	Thomas James Doyle	Svp, Finance Accounting	142,428	0	142,428	9.3%	29 Sep, 2026
6	Mollie Leoni	Chief Medical Officer	141,095	0	141,095	9.2%	29 Sep, 2026
7	Brian T. Powl	Chief Commercial Officer	136,819	0	136,819	9.0%	29 Sep, 2026
8	Francis Burrows	Chief Scientific Officer	42,327	0	42,327	2.8%	25 Sep, 2026
9	Stephen Dale	Chief Medical Officer	38,817	0	38,817	2.5%	31 Jan, 2024
10	Faheem Hasnain	Director	23,983	0	23,983	1.6%	10 Dec, 2025
11	Marc Grasso	Cfo, Cbo	21,900	0	21,900	1.4%	28 Jan, 2022
12	Kirsten Flowers	Cco Chief Strategy Officer	20,605	0	20,605	1.3%	31 Jan, 2023

Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.

Form 4 Filings

396 Insider Transactions

Source SEC Form 4

Latest quarter Sep 2026

Date	Insider	Position	Transaction	Shares	Price	Value	Shares Held After	Ownership
28 Sep, 2026	Kathleen Ford	Chief Operating Officer	Disposed S	6,906	$10.50	$72.49K	146,654	Direct
28 Sep, 2026	Brian T. Powl	Chief Commercial Officer	Disposed S	9,020	$10.50	$94.69K	160,249	Direct
28 Sep, 2026	Teresa Brophy Bair	Chief Legal Officer	Disposed S	8,442	$10.50	$88.62K	187,002	Direct
28 Sep, 2026	Thomas James Doyle	Svp, Finance Accounting	Disposed S	4,607	$10.50	$48.36K	142,428	Direct
28 Sep, 2026	Mollie Leoni	Chief Medical Officer	Disposed S	12,448	$10.50	$130.67K	169,897	Direct
29 Sep, 2026	Kathleen Ford	Chief Operating Officer	Disposed S	3,668	$10.75	$39.44K	142,986	Direct
28 Sep, 2026	Brian T. Powl	Chief Commercial Officer	Disposed S	8,000	$10.56	$84.50K	152,249	Direct
29 Sep, 2026	Mollie Leoni	Chief Medical Officer	Disposed S	28,802	$10.75	$309.57K	141,095	Direct
29 Sep, 2026	Brian T. Powl	Chief Commercial Officer	Disposed S	15,430	$10.75	$165.85K	136,819	Direct
24 Sep, 2026	Francis Burrows	Chief Scientific Officer	Acquired M	30,000	$6.15	$184.50K	63,053	Direct
24 Sep, 2026	Francis Burrows	Chief Scientific Officer	Disposed S	20,726	$10.83	$224.51K	42,327	Direct
24 Sep, 2026	Francis Burrows	Chief Scientific Officer	Disposed M	30,000	$0.00	$0	0	Direct
08 Sep, 2026	Jennifer Fulk	Chief Financial Officer	Acquired A	450,000	$0.00	$0	450,000	Direct
24 Aug, 2026	Troy Edward Wilson	President And Ceo	Acquired P	100,000	$12.39	$1.24Mn	479,194	Indirect
21 Aug, 2026	Brian T. Powl	Chief Commercial Officer	Disposed S	4,345	$11.89	$51.66K	169,269	Direct
19 Aug, 2026	Teresa Brophy Bair	Chief Legal Officer	Disposed S	31,487	$12.63	$397.68K	195,444	Direct
17 Aug, 2026	Troy Edward Wilson	President And Ceo	Acquired P	100,000	$11.12	$1.11Mn	379,194	Indirect
18 Jun, 2026	Mollie Leoni	Chief Medical Officer	Disposed S	84,929	$9.82	$834.28K	182,345	Direct
04 Jun, 2026	Faheem Hasnain	Director	Acquired A	35,000	$0.00	$0	35,000	Direct
04 Jun, 2026	Carol Schafer	Director	Acquired A	35,000	$0.00	$0	35,000	Direct

Showing 1 to 20 of 396 transactions